SAN DIEGO--(BUSINESS WIRE)--Inc. magazine today ranked global genetic testing company Pathway Genomics No. 173, with a three-year growth rate of 2,415.5%, on its 33rd annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy — America’s independent entrepreneurs. Companies such as Yelp, Pandora, Timberland, Dell, Domino’s Pizza, LinkedIn, Zillow, and many other well-known names gained early exposure as members of the Inc. 500|5000.
“A heartfelt congratulations to each company that made the Inc. 500|5000. We are honored to be included among the top-tier of innovative companies in the nation,” said Jim Plante, Pathway Genomics’ founder and CEO. “Since the day Pathway was founded, it has been our goal to provide the most accurate and pioneering services possible to physicians and their patients. These last few years have been an incredible ride in developing a suite of powerful tests that can benefit patients worldwide to truly make an impact on global health – and we’re just getting started.”
As a government-accredited clinical laboratory and forward-thinking healthcare company, Pathway Genomics has numerous actionable genetic tests that can identify a person’s genetic risk for cancer, cardiac conditions, inherited diseases, nutrition and exercise response, and drug response for medications, specifically those used in pain management and mental health.
Over the last two months, Pathway Genomics has launched a leading-edge next-generation sequencing breast cancer risk genetic test, called BRCATrueTM, and co-hosted a fundraiser benefiting Susan G. Komen that raised more than $300,000 for the organization. The company also unveiled the BRCA One for OneTM program – for every qualified BRCATrue test ordered, one test is donated to a person in need, up to $10 million of free testing. It is the only program of its kind in the history of the medical community. Pathway Genomics also has a financial assistance program for patients who cannot afford testing.
The 2014 Inc. 500, unveiled in the September issue of Inc. (available on newsstands August 20 to November 15 and on Inc.com), is the most competitive crop in the list’s history. To make the cut, companies had to have achieved a staggering minimum of 942.6% in sales growth. The Inc. 500’s aggregate revenue is $15.2 billion, with a median three-year growth of 1,828%, generating 23,000 jobs over the past three years. Complete results of the Inc. 500|5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.
"What surprises me, even though I know it’s coming, is the sheer variety of the paths our entrepreneurs take to success, thematically reflecting how our economy has evolved,” said Inc. President and Editor-In-Chief Eric Schurenberg. “This year there are far more social media and far fewer computer hardware businesses than there were, say, six years ago. But what doesn’t change is the fearsome creativity unleashed by American entrepreneurship.”
The annual Inc. 5000 event honoring all the companies on the list will be held from October 15 through 17, 2014 in Phoenix. Speakers include some of the greatest entrepreneurs of this and past generations, such as Michael Dell, Martha Stewart, host of the CNBC show “The Profit” Marcus Lemonis, Container Store Founder and CEO Kip Tindell, and Chobani Founder and CEO Hamdi Ulukaya.
About Pathway Genomics Corporation
As a CLIA and CAP accredited clinical laboratory based in San Diego, California, Pathway Genomics provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation and commitment to medical responsibility – making it a leader in the commercial genetic testing industry. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.
More About Inc. and the Inc. 500|5000
Methodology
The 2014 Inc. 500|5000 is ranked according to percentage revenue growth when comparing 2010 to 2013. To qualify, companies must have been founded and generating revenue by March 31, 2010. They had to be U.S.-based, privately held, for profit, and independent--not subsidiaries or divisions of other companies--as of December 31, 2013. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2010 is $100,000; the minimum for 2013 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.'s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.
About Inc. and the Inc. 500|5000
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today's innovative company builders. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 6,000,000 today. For more information, visit http://www.inc.com/.
The Inc. 500|5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success. The Inc. 500|5000 Conference & Awards Ceremony is an annual event that celebrates their remarkable achievements. The event also offers informative workshops, celebrated keynote speakers, and evening functions. For more information on Inc. and the Inc. 500|5000 Conference, visit http://www.inc.com/.
